Health Care · Surgical & Medical Instruments & Apparatus

TFX Teleflex Inc SEC Filings & Insider Trading Activity 2026

company
CIK 9694396 filings

TFX at a glance

Teleflex Inc (TFX, SEC CIK 96943) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as September 10, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Teleflex Inc (TFX) reported revenue of $2.0 billion (down 34.6% from FY2024) and a net loss of $905.6 million. Diluted EPS was -$20.25.
  • As of September 30, 2026, 32 institutional investment managers tracked by SignalX reported holding Teleflex Inc (TFX) shares worth $2.2 billion in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$2.0B
−34.6% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
32 funds
$2.2B · −2 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02 · Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $567.8M, up $0.9M, or 0.2% YoY
  • Gross margin 65.0% vs 51.5% YoY, aided by tariff refunds and nonrecurring inventory step-up
  • Best segment Vascular: revenue $243.5M, up 4.7%; worst Interventional: revenue $210.3M, down 2.6%
  • Operating cash flow $234.8M vs $10.3M; $555.0M share repurchases and $1.0B debt reduction
  • Outlook: tariff impacts remain uncertain; Acute Care and IU sale may extend into 2027

Risk Factors

  • Newly added shareholder activism risk: Irenic’s March 27, 2026 campaign seeks board changes and strategic-alternatives review
  • Most material update: activist proposals could divert management attention and increase advisory costs
  • Market risk: activism may trigger stock-price volatility unrelated to business fundamentals
  • Operational risk: perceived uncertainty could hinder retention of qualified personnel and customer relationships

AI summary of the TFX 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results announced for quarter ended September 30, 2026, with detailed figures in Exhibit 99.1
  • Non-GAAP metrics emphasize pro forma revenue, constant-currency growth and adjusted diluted EPS

Item 7.01: Regulation FD Disclosure

  • Slide presentation supports Teleflex’s November 5, 2026 conference call on third-quarter results
  • Results cover the quarter ended September 30, 2026

Item EX-99.1: Item EX-99.1

  • Q3 revenue $567.8M, up 3.0% pro forma constant currency, with Vascular +4.6% and Surgical +5.1%
  • Adjusted EPS $2.63 versus $1.89, while adjusted operating margin reached 25.0%

Item EX-99.2: Item EX-99.2

  • Q3 adjusted EPS $2.63, up 39.2% year over year, supported by higher margins, lower interest expense, fewer shares and tariff refunds
  • OEM divestiture closed for $1.5B proceeds, $1.25B after tax, funding planned debt reduction and share repurchases
Filed Sep 9, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Board expanded from eight to nine directors, adding governance capacity and healthcare-industry expertise
  • Sean M. Salmon elected director, bringing 21 years of Medtronic leadership across cardiovascular and diabetes businesses

Item 7.01: Regulation FD Disclosure

  • Board appointment announcement for Mr. Salmon, effective September 8, 2026
  • Governance change may influence board oversight, strategy and shareholder representation

Item EX-99.1: Item EX-99.1

  • Sean M. Salmon appointed to Teleflex’s nine-member Board, effective September 8, 2026
  • Eight of nine directors now independent, supporting governance credibility and board refreshment
Filed Aug 7, 2026Full analysis →

Item 8.01: Other Events

  • $250 million accelerated share repurchase under Teleflex’s existing $1 billion authorization
  • Initial share delivery valued at 80% of the repurchase price on August 10, 2026

AI summaries of TFX 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for TFX

Don't miss the next TFX filing

  • Alerts as it files. A push when TFX files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut TFX, by share count.
  • Ask anything. An AI agent that reads every TFX filing and answers with sources.

TFX alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Salmon SeanASep 8, 2026-
Salmon SeanASep 8, 2026-
Weidman Jason R.AJun 8, 2026-
Weidman Jason R.AJun 8, 2026-
RANDLE STUART AAJun 8, 2026-
RANDLE STUART AAJun 8, 2026-
RANDLE STUART AAJun 8, 2026-
RANDLE STUART AFJun 7, 2026$129.84

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$3.0B$2.0B
Gross Profit-$1.7B$1.1B
Operating Income-$151.0M$118.4M
Net Income-$69.7M-$905.6M
Gross Margin-55.9%56.2%
Op. Margin-5.0%5.9%
Net Margin-2.3%-45.4%
Balance Sheet
Total Assets$7.5B$7.1B$6.9B
Equity$4.4B$4.3B$3.1B
ROE-1.6%-29.0%
Per Share
EPS-$1.48$-20.25
Cash Flow
Operating CF-$638.3M$96.7M
CapEx-$126.4M$95.2M

Source: XBRL data in Teleflex Inc (TFX)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate TFX share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
TFX shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202632$2.19B
Q2 202634$2.69B
Q1 202633$2.26B
Q4 202531$2.55B
Q3 202532$2.63B
Q2 202532$2.30B
Q1 202530$2.06B
Q4 202428$2.01B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 252 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

TFX filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 5, 2026Analysis
8-KNov 5, 2026Analysis-
4Sep 10, 2026--
8-KSep 9, 2026Analysis-
8-KAug 7, 2026Analysis-
10-QAug 6, 2026-
8-KAug 6, 2026Analysis-
8-KAug 5, 2026Analysis-
8-KAug 3, 2026Analysis-
8-KJun 15, 2026--
4Jun 9, 2026-
8-KJun 9, 2026-
4Jun 9, 2026-
8-KJun 2, 2026-
8-KJun 1, 2026-
8-KMay 27, 2026-
8-KMay 20, 2026-
4May 19, 2026-
4May 12, 2026-
10-QMay 7, 2026-
8-KMay 7, 2026-
8-KApr 30, 2026--
8-KMar 27, 2026--
8-KMar 17, 2026Analysis-
4Mar 5, 2026--

Related Health Care companies

All Health Care →

TFX SEC filings: frequently asked questions

Which institutions hold TFX stock?

As of September 30, 2026, the largest Teleflex Inc (TFX) holders among the 13F filers tracked by SignalX were BlackRock ($651.8 million), Vanguard Portfolio Management LLC ($290.7 million), Vanguard Capital Management LLC ($238.2 million), State Street Corp ($180.4 million), Dimensional Fund Advisors ($147.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was TFX's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Teleflex Inc (TFX) reported revenue of $2.0 billion (down 34.6% from FY2024) and a net loss of $905.6 million. Diluted EPS was -$20.25. The figures come from the XBRL data in the 10-K.

What did TFX report in its latest 8-K?

Teleflex Inc (TFX) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 2026 results announced for quarter ended September 30, 2026, with detailed figures in Exhibit 99.1.

What are the latest TFX SEC filings?

Teleflex Inc (TFX) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on September 10, 2026.

What is TFX's SEC CIK number?

Teleflex Inc (TFX)'s SEC Central Index Key (CIK) is 96943. EDGAR lists every TFX filing under that number.

Ask anything about TFX

The research agent reads TFX's filings, financials, insider trades and 13F holders, then answers with sources.